Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00283114
Status:
COMPLETED
Last Update Posted:
2014-12-18
First Post:
2006-01-25
Brief Title:
A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Myelomonocytic Leukemia |
| Acute Myeloid Leukemia |
| Myelodysplastic Syndrome |
| Myeloproliferative Disorders |